Study results positive for drug Amgen developing to treat osteoporosis
Thousand Oaks-based biotech giant Amgen and Brussels, Belgium-based UCB announced positive results in a Phase 3 trial of romosozumab, an antibody designed to treat osteoporosis. The drug works by inhibiting a protein which results in increased bone formation and decreased bone breakdown. However, the drug is not approved by any regulatory authority for use to Read More →
Small businesses take to streets to sell goods
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Thousand Oaks’ New West Symphony creates new experiences
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Dubroff: Santa Barbara takes a regional view of innovation culture
In a sign that the current wave of tech entrepreneurship might just be sustainable, cities across the Tri-Counties are beginning to embrace the startup culture. San Luis Obispo is thinking about housing a much bigger tech savvy workforce, working closely with Cal Poly and capitalizing on the success of MindBody. Ventura is looking beyond the Read More →
Volunteerism ‘shapes community we share’
In business, we measure success by revenue growth, rising profits, share prices and transactions closed. But in communities across the Tri-Counties, successful leadership is often defined by measures less tangible. That point was brought home on March 9 when we stopped by the Santa Barbara Foundation’s 73rd annual Man and Woman of the Year luncheon. Read More →
Fischbach: Earn loyalty by making customers smarter
My mobile phone has become more of a need than a want. Anyone who loses or breaks a phone learns quickly how much of life revolves around a mobile device. Industry insiders report the average consumer unlocks their mobile device over 150 times per day. Content marketing has become a great way for businesses to Read More →
Amgen wins lawsuit against Regeneron, Sanofi for violating patents
A federal jury decided in favor of Amgen on March 16 in a lawsuit filed against Regeneron Pharmaceuticals and Sanofi for violating patents on a cholesterol reducing drug. In October 2014, Thousand Oaks-based Amgen sued Paris-based Sanofi and Tarrytown, N.Y.-based Regeneron for violating patents on its cholesterol reducing drug Repatha. Sanofi and Regeneron co-developed Praluent Read More →
